---
title: "valproic acid - Bipolar disorder"
sidebar: mydoc_sidebar
permalink: valproicacidbipolardisorder2.html
toc: false 
---

{% include image.html file="valproicacidbipolardisorder2.png" alt="valproicacidbipolardisorder2" %}![Path Visualization](/images/valproicacidbipolardisorder2.png)

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:D014635 | valproic acid | Drug |
| UniProt:P29966 | Myristoylated alanine-rich C kinase substrate | Protein |
| UniProt:P17252 | Protein kinase C alpha type | Protein |
| UBERON:0001870 | frontal cortex | GrossAnatomicalStructure |
| GO:0051823 | synaptic remodeling | BiologicalProcess |
| MESH:D001714 | Bipolar disorder | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Valproic Acid | NEGATIVELY REGULATES | Myristoylated Alanine-Rich C Kinase Substrate |
| Myristoylated Alanine-Rich C Kinase Substrate | NEGATIVELY REGULATES | Protein Kinase C Alpha Type |
| Protein Kinase C Alpha Type | LOCATED IN | Frontal Cortex |
| Frontal Cortex | CONTRIBUTES TO | Synaptic Remodeling |
| Synaptic Remodeling | TREATS | Bipolar Disorder |
|---------|-----------|---------|

Reference: [https://go.drugbank.com/drugs/DB:DB00313#mechanism-of-action](https://go.drugbank.com/drugs/DB:DB00313#mechanism-of-action){:target="_blank"}